The landscape of human epidermal growth factor receptor 2 (HER2) expression in gynecologic tumors (GTs)

被引:0
作者
Duran, C. Garcia [1 ]
Musacchio, L. [2 ]
Mazzeo, R. [3 ]
Carita, L. [4 ]
Jimenez, J. [5 ]
Bejar, J. F. Grau [6 ]
Illescas, D. G. [7 ]
Fasani, R. [8 ]
Madrid, L. Farinas [1 ]
Villacampa, G. [9 ]
Oaknin, A. [7 ]
机构
[1] Vall dHebron Inst Oncol, Med Oncol Dept, Barcelona, Spain
[2] Fdn Policlin Univ Agostino Gemelli IRCC, Gynecol Oncol Unit, Rome, Italy
[3] Univ Udine, Med Oncol, Dipartimento Area Med DAME, Udine, Italy
[4] VHIO Valle Hebron Inst Oncol, Oncol Data Sci, Barcelona, Spain
[5] Vall dHebron Inst Oncol, Pathol Anat, Barcelona, Spain
[6] Vall dHebron Inst Oncol, Med Oncol Serv, Barcelona, Spain
[7] Vall dHebron Barcelona Hosp Campus, Vall dHebron Inst Oncol, Med Oncol Serv, Barcelona, Spain
[8] Barcelona Vall dHebron Inst Oncol VHIO, Cellex Ctr, Barcelona, Spain
[9] Vall dHebron Inst Oncol, Stat Dept, Barcelona, Spain
关键词
D O I
10.1016/j.annonc.2024.08.2150
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
790P
引用
收藏
页码:S590 / S591
页数:2
相关论文
共 50 条
  • [31] Human epidermal growth factor receptor families (EGFR, HER2) and survival in colorectal adenocarcinoma
    Molaei, M.
    Pejhan, S.
    Emami, S.
    Ghiasi, S.
    Mashayekhi, R.
    Zali, M.
    Motlagh, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 90 - 90
  • [32] Targeting the Human Epidermal Growth Factor Receptor Family in Breast Cancer beyond HER2
    Riecke, Kerstin
    Witzel, Isabell
    BREAST CARE, 2020, 15 (06) : 579 - 585
  • [33] Expression of Epidermal Growth Factor Receptor and HER-2 in Pediatric Embryonal Brain Tumors
    Patereli, Amalia
    Alexiou, George A.
    Stefanaki, Kalliopi
    Moschovi, Maria
    Doussis-Anagnostopoulou, Ipatia
    Prodromou, Neofytos
    Karentzou, Ourania
    PEDIATRIC NEUROSURGERY, 2010, 46 (03) : 188 - 192
  • [34] Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT)
    Siddiqui, Mohammad R.
    Railkar, Reema
    Sanford, Thomas
    Crooks, Daniel R.
    Eckhaus, Michael A.
    Haines, Diana
    Choyke, Peter L.
    Kobayashi, Hisataka
    Agarwal, Piyush K.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [35] Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT)
    Mohammad R. Siddiqui
    Reema Railkar
    Thomas Sanford
    Daniel R. Crooks
    Michael A. Eckhaus
    Diana Haines
    Peter L. Choyke
    Hisataka Kobayashi
    Piyush K. Agarwal
    Scientific Reports, 9
  • [36] Unique molecular signatures of germline mutations in low expression of human epidermal growth factor receptor 2 (HER2) breast cancer
    Liao, Ning
    Zhang, Weiqi
    Liu, Liangqiu
    Wu, Wendy
    Wang, Siqi
    Cao, Li
    Lai, Jianguo
    Zhang, Xueying
    Yang, Airong
    Wang, Yulei
    Li, Cheukfai
    Zhang, Guochun
    Ren, Chongyang
    Wen, Lingzhu
    CANCER RESEARCH, 2024, 84 (09)
  • [37] Gene Expression and miRNAs Profiling: Function and Regulation in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
    Sareyeldin, Rasha M.
    Gupta, Ishita
    Al-Hashimi, Israa
    Al-Thawadi, Hamda A.
    Al Farsi, Halema E.
    Vranic, Semir
    Al Moustafa, Ala-Eddin
    CANCERS, 2019, 11 (05)
  • [38] Investigation of Affinity at Binding Site Between Human Epidermal Growth Factor Receptor 2 (HER2) and Herceptin
    Kondrashova, Maria
    Miller, Bill
    FASEB JOURNAL, 2017, 31
  • [39] Recent progress in immunotherapy of breast cancer targeting the human epidermal growth factor receptor 2 (HER2)
    Seyedmirzaei, Homa
    Keshavarz-Fathi, Mahsa
    Razi, Sepideh
    Gity, Masoumeh
    Rezaei, Nima
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (05) : 1235 - 1244
  • [40] MHC Class I Expression in Uterine Serous Carcinoma With and Without Human Epidermal Growth Factor Receptor 2 (HER2) Amplification
    Ribeiro e Ribeiro, Renan
    Hansen, Katrine
    Sung, C. James
    Quddus, M. Ruhul
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 737 - 738